February 23, 2022
Article
The 2019 Strategic Plan of the Infectious Diseases Society of America lays the groundwork for understanding prescribing practices.
October 14, 2019
Novel β-lactam/β-lactamase inhibitor combinations and cefiderocol may play a part in the treatment of infections caused by Stenotrophomonas maltophilia, Achromobacter xylosoxidans, and Burkholderia cepacia complex.
Regdanvimab—A New Attack of the (Mono)Clones
FDA Lifts Clinical Hold of Lenacapavir for HIV Treatment and Prevention
First In-Africa Clinical Trial of mRNA HIV Vaccine
Fourth COVID-19 Vaccine Dose Boosts Immunity Above Third Shot